New search
Property profile & analytics
FOR LEASE
Life science properties
300 Ballardvale St, Wilmington, MA 01887
Entity Owned
3-yr Hold
~
Est. High Equity
Property ID
US38-1750028
For Lease
1 / 4
$13,140,000
300 Ballardvale St, Wilmington, MA 01887
View Listing →
Property profile
Verified
Property type
Life science properties
Use group
R&D FACILITY, LABS, PHARMA
Year built
1985
Construction
STEEL FRAME
Total area
103,246 SF
Lot
3.55 ac (154,638 SF)
APN
WILM M:00R3 L:0000 P:0029A
UPID
US38-1750028
Cap rate & NOI
Priority signal for investors
Implied cap rate, NOI & suggested price
Cap rate vs submarket · NOI estimate · 3 price anchors
Implied cap rate, NOI & suggested price
Cap vs submarket · NOI estimate · 3 price anchors
Current use
Occupant on record · Public records
-
Quiet Logistics Warehouse & Storage
-
FedEx Drop Box Postal Service Courier Service
-
AVI Systems IT Consulting Firm Tech Support Center
-
BAYADA Home Health Hospice Home Health Care Service
Value estimations
Realmo proprietary · 4 methods
AI Approach
AI
$8.51M
CAP Approach
CAP
by Request
Comparable Approach
Comparable
$8.64M
Blend (final)
Blend
$13.14M
Owner & transaction history
Bac&cb Ballardvale LLC · 3 yrs held
Bac&cb Ballardvale LLC
since 2022
Last sale
$17.0M
7 recorded transactions
Zoning & alternative use
Permitted uses
Permitted uses
Allowed · conditional · prohibited
Cap rate
Implied · in-place · derived from last sale + estimated NOI
Implied Cap rate
#1
Implied · in-place · NOI ÷ last sale
In-place · derived from last sale + estimated NOI
Cap rate, NOI & submarket benchmark
Implied cap rate vs Wilmington submarket · NOI estimate · Typical band, median & reading
Implied cap rate, NOI & submarket benchmark
Cap vs Wilmington submarket · NOI estimate · typical band, median & reading
Refine your cap rate
8-question underwriting flow
1.
Property current status — Going-In vs Stabilized
2.
Price for denominator — asking / offer / market
3.
Leasing status & lease structure (NNN / Gross)
4.
Tenant risk profile & vacancy assumption
5.
Upload T12 / rent roll / OM (optional)
Refine in 60 seconds, get exact suggested price
T12 upload · Submarket benchmarks · Sensitivity grid
Suggested price · 3 cap rate anchors
Income approach @ 5% / 7% / 9% — aggressive / typical / conservative
Suggested price at 5% / 7% / 9% cap
Aggressive / typical / conservative · Implied $/SF per anchor · Sensitivity grid
Suggested price at 5% / 7% / 9% cap
Aggressive / typical / conservative · implied $/SF · sensitivity
Value
AI, CAP & Alternative Use estimations · Realmo proprietary blendValue Estimations
Based on Realmo’s proprietary methodology
AI Approach
Method
Estimation
Statistic approach
$14,570,000
ML approach
$8,505,000
CAP Approach
CAP Return
Estimation
6%
by Request
6.5%
by Request
7%
by Request
Alternative Use
Use
Estimation
R&D FACILITY, LABORATORY, RESEARCH FACILITY, COSMETICS, PHARMACEUTICAL
$16,830,000
Current use
Blend value · Realmo final
$13.14M
Range $11.83M – $14.45M · ±10% · vs last sale $17.00M (Oct 7 2022)
Last sale anchor
$17.00M
Oct 7 2022
Realmo estimate · informational only.
These numbers are calculated by our models from public records and may not reflect actual market value.
Not an appraisal.
Verify with a licensed appraiser before transacting. Realmo accepts no liability for divergence from real-world outcomes.
View the full estimation — every method, every assumption
Confidence drivers & risk notes · Custom comparable set · Free for first 3 / day
Full estimation methodology
Every method · every assumption · confidence drivers
Price per SF
Sale + rent benchmarks
Subject property
$127 / SF
Submarket sale & rent benchmarks
Median sale $/SF · Asking & closed rent · Submarket vacancy
Submarket sale & rent benchmarks
Median sale $/SF · asking & closed rent · submarket vacancy
Property tax & assessments
Tax year 2024Property tax & assessments
Tax year 2024
Tax billed
$85,289
Tax year 2024
Assessed value
$3,251,600
Assessed 2024
Previous assessed
$2,992,300
+8.7% YoY
Effective rate
2.62%
On assessed value
Assessed land
$1,529,800
Assessed improvement
$1,721,800
Comparables
6 recent transactions · within 1.5 miComparable in this city
6 recent transactions
Comparable in this City
Recent comparable sales
Sale price & price/SF · Sale date & distance · Adjustments & confidence
Recent comparable sales
Sale price & $/SF · sale date & distance · adjustments
Property description
Physical attributes from public recordsBuilding & lot
Public records
Property type
Life science properties
Use group
R&D FACILITY, LABS, PHARMA
Status
For Lease
Year built
1985
Construction
STEEL FRAME
Heating
FORCED AIR
Cooling
YES
Buildings
1
Stories
2
Units
8
Bathrooms
2
Total area
103,246 SF
Lot
3.55 ac (154,638 SF)
APN
WILM M:00R3 L:0000 P:0029A
UPID
US38-1750028
Jurisdiction
WILMINGTON
Metro division
CAMBRIDGE-NEWTON-FRAMINGHAM, MA METROPOLITAN DIVISION
Zoning & alternative use
Zoning · permitted uses
Permitted & conditional uses
Allowed uses · Special-permit conditions · Prohibited uses
Permitted & conditional uses
Allowed · special-permit conditions · prohibited
Alternative use value scenarios
Repositioning upside vs current use
R&D FACILITY, LABORATORY, RESEARCH FACILITY, COSMETICS, PHARMACEUTICAL Current
Est. value
$16.8M
R&D FACILITY, LABORATORY, RESEARCH FACILITY, COSMETICS, PHARMACEUTICAL Current
Alternative use deep dive — conversion cost, permits, timeline
Conversion cost estimate · Permit path & risks · Stabilized NOI per option
Alternative use deep dive
Conversion cost · permit path · stabilized NOI per option
Building & site characteristics
From public records
Year built
1985
Construction
STEEL FRAME
Heating
FORCED AIR
Cooling
Yes
Stories
2
Buildings
1
Units
8
Bathrooms
2
Lot
3.55 ac
Current owner
From public records · entity-resolved
Bac&cb Ballardvale LLC
Entity
Mailing address
300 BALLARDVALE ST, WILMINGTON, MA 01887-1012
Ownership since
2022
Owner contacts — direct phone, email, and related entities
Decision-maker phone · Verified email · Related entities & filings
Owner contacts
Email · phone · related entities
Sales History
7 recorded events · public records
Date
Price
Buyer
Seller
Deed Type
Mortgage
Oct 7, 2022
$17,000,000
Bac&cb Ballardvale LLC
Cbe 300 Ballardvale LLC
Quit Claim Arm's Length For Ne States
$13,500,000 · Salem Five Cents Savings Bank
Mar 22, 2021
$10,000,000
Cbe 300 Ballardvale LLC
Wcv 299-301 Ballardvale
Quit Claim Arm's Length For Ne States
$8,077,465 · Middlesex Savings Bank
Dec 8, 2015
$22,200,000
Berkeley Ballardvale LLC
Bre East Mixed Asset Ownr
Quit Claim Deed
related
—
Aug 5, 2015
$2,580,649
Bre East Mixed Asset Ownr
General Electric Credit
Quit Claim Deed
—
Oct 2, 2013
$16,000,000
Electric Credit
299-301 Ballardvale Assoc
Foreclosure
related
—
Jun 13, 2006
$12,500,000
299-301 Ballardvale LLC
Ballardvale T
Grant Deed
$26,353,400 · General Electric Capital Corp
Jun 18, 1998
—
T Ballardvale
—
Deed Of Trust
related
$1,000,000 · Brookline Savings Bank
Coming soon
Costs & Benchmarks
Operating expenses, capex projections, utility benchmarks, and submarket comparables — all in one view.
Coming soon
Risks
Flood, climate, environmental, title, and tenant-concentration risk — surfaced with mitigations and source citations.
Try Rey
Ask anything about this address in plain English.
“Is 15.6% cap rate sustainable?” · “Best tenant mix for BU1?” · “What’s the redev upside?”
Full reports are paid
Unlock the full Property Analytics report
Start free for 7 days — no card required. Full owner contacts, all 4 valuations with methodology, refine flow, comparable adjustments, foot-traffic deep dive, export to PDF / CSV.
